Complimentary U.S. shipping on orders over $250 American-manufactured Independently verified Documentation on request
01 Catalog Tesamorelin (5MG) stabilized GHRH analog research peptide vial — BioFusion Aminos
Catalog

Tesamorelin (5MG)

Tesamorelin (5MG) lyophilized peptide for laboratory research. HPLC-verified ≥99% purity, batch-specific COA, American-manufactured. Ships 24h.

$55.00


Proceed to Checkout

Research Use Only. Not for human or veterinary use.

American-manufactured Ships 24-48h Research Use Only
About the Standard

Documented reference chemistry.

Tesamorelin — a 44-residue stabilized GHRH-analog research peptide — supplied by BioFusion as a vacuum-sealed lyophilized 5mg vial for full-length GHRH-pathway research chemistry.

Research context

Tesamorelin is the trans-3-hexenoyl-modified version of the natural 44-residue GHRH(1-44) sequence — a structural modification at the N-terminus that improves stability and receptor-research kinetics relative to native GHRH. As the longest standard reference in the GHRH research panel, Tesamorelin is the typical control compound when comparing the truncated CJC-1295 and CJC-1295 no DAC analogs against full-length GHRH.

Synthesis & documentation

Produced by solid-phase peptide synthesis using Fmoc protecting-group strategy in a U.S.-based ISO 9001:2008 facility, with the trans-3-hexenoyl modification incorporated post-cleavage. Each lot is verified for identity (LC-MS), purity (reverse-phase HPLC-UV ≥99.0%), moisture (Karl Fischer), and counter-ion (ion chromatography). Signed COA ships with every order; lot archive on the COA library.

Storage & handling

Lyophilized Tesamorelin is stable at −20 °C for the printed shelf life. After reconstitution, the standard 14-day-at-2-8 °C reference window applies; avoid freeze-thaw cycling. At 44 residues, Tesamorelin is more aggregation-prone than shorter GHRH analogs — use mild solvents (bacteriostatic water or saline) rather than aggressive co-solvents. The reconstitution calculator handles concentration math.

Why BioFusion

Synthesizing 44-residue peptides at ≥99% HPLC purity is technically demanding — sequence length increases the probability of single-residue deletion impurities. BioFusion’s Tesamorelin is purified to ≥99.0% reverse-phase HPLC purity at every release, with synthesis-date metadata on the batch transparency ledger. Bulk discounts at three+; members save 25% plus free U.S. shipping for 365 days.

For research and laboratory use only. This product is not a drug, food, or cosmetic, and is not intended for diagnostic, therapeutic, or in vivo human use.

From the Same Class

Related reference standards.

View the catalog →